MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Medinotec statistics
Financials through Aug 31, 2026, price as of Oct 16, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Medinotec | Industry median |
|---|---|---|
| Market Cap | $58.78M | $230.55M |
| Enterprise Value | $58.17M | $202.97M |
| PS Ratio | 5.76 | 3.11 |
| PB Ratio | 9.91 | 3.14 |
| P/TBV Ratio | 9.91 | 4.57 |
| P/OCF Ratio | 157.20 | 22.35 |
Enterprise value
| Measure | Medinotec | Industry median |
|---|---|---|
| EV / Sales | 5.70 | 2.92 |
| EV / EBITDA | 74.48 | 19.86 |
| EV / EBIT | 86.55 | 24.88 |
Income (trailing twelve months)
| Measure | Medinotec | Industry median |
|---|---|---|
| Revenue | $10.21M | $102.39M |
| Gross Profit | $5.07M | $60.36M |
| Operating Income | $672.09K | -$4.31M |
| Pretax Income | $658.34K | -$2.26M |
| Net Income | $597.03K | -$6.57M |
| EBITDA | $781.06K | -$1.98M |
Margins
| Measure | Medinotec | Industry median |
|---|---|---|
| Gross Margin | 49.6% | 55.1% |
| Operating Margin | 6.58% | -6.04% |
| Pretax Margin | 6.45% | -4.11% |
| Profit Margin | 5.85% | -10.5% |
| EBITDA Margin | 7.65% | -2.67% |
Returns
| Measure | Medinotec | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.1% | -19.2% |
| Return on Assets (ROA) | 8.96% | -13.3% |
| Return on Invested Capital (ROIC) | 17.9% | -4.11% |
| Return on Capital Employed (ROCE) | 11.2% | -9.07% |
Growth
| Measure | Medinotec | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -10.9% | 8.85% |
| Net Income Growth (YoY) | -73.4% | 10.6% |
| Revenue Growth (3Y CAGR) | 113.5% | 7.08% |
Balance sheet
| Measure | Medinotec | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.58M | $37.33M |
| Total Debt | $497 | $72.66M |
| Net Cash (Debt) | $2.58M | $3.92M |
| Net Cash Per Share | $0.22 | $0.28 |
| Equity (Book Value) | $5.93M | $57.36M |
| Book Value Per Share | $0.50 | $2.81 |
| Tangible Book Value | $5.93M | $10.71M |
| Working Capital | $5.48M | $54.64M |
Financial position
| Measure | Medinotec | Industry median |
|---|---|---|
| Current Ratio | 6.74 | 2.50 |
| Quick Ratio | 5.45 | 1.54 |
| Debt / Equity | 0.00 | 0.38 |
| Debt / EBITDA | 0.00 | 2.31 |
| Net Debt / EBITDA | -3.31 | 1.53 |
| Interest Coverage | 21.76 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Medinotec | Industry median |
|---|---|---|
| Operating Cash Flow | $373.90K | -$653.46K |
Efficiency
| Measure | Medinotec | Industry median |
|---|---|---|
| Asset Turnover | 1.53 | 0.59 |
| Revenue Per Employee | $212.73K | $322.57K |
| Profits Per Employee | $12.44K | -$51.88K |
| Employee Count | 48 | 185 |
Dividends and yields
| Measure | Medinotec | Industry median |
|---|---|---|
| Earnings Yield | 1.02% | -6.91% |
Shares
| Measure | Medinotec | Industry median |
|---|---|---|
| Shares Outstanding | 11,755,500 | 44,856,700 |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 1,841,150 | 37,097,900 |
| Shares Held by Insiders | 84.3% | 10.6% |
Scores
| Measure | Medinotec | Industry median |
|---|---|---|
| Altman Z-Score | 37.35 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.45 | -2.64 |
Calculated by StockData from Medinotec's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.